Acumen research and consulting estimates that the global clinical trial management system market is anticipated to reach market size of around US$ 2,500 Mn by 2027 and is anticipated to grow at a CAGR of around 8% in terms of revenue during the forecast period 2020 – 2027. Clinical trials are standard ways to determine the health and effectiveness of a pharmaceutical drug or some other medical tool. Due to substantial growth in the production of the wide variety of health care supplies, medicines and facilities, the global clinical trial management program industry has been growing in recent years. By December 6, 2017, approximately 260,848 clinical trials have been publicly registered worldwide, according to the ClinicalTrials.gov update. Each year the figure increases gradually.
Market Insights
In combination with the rising trend of outsourcing clinical trials, the high prevalence of chronic diseases worldwide fuels the growth in the clinical research management systems market during the forecast. Increased public and private R&D funding will boost business growth. In addition, the presence of stringent regulations governing the enforcement of clinical trials will accelerate the growth of the clinical trials industry globally. The growing need for innovative clinical research management systems in IT will boost the market over the next few years to improve monitoring controls over clinical trials. The ability to manage complex protocol designs in clinical trials and timelines will improve its adoption in the series of statistical future, by streamlining processes. In addition, government attempts to encourage international corporations to perform clinical trials and raise foreign reserves for investment of finance and technology would promote economic growth. However, during the analysis period, high costs associated with clinical trials will hinder growth in the market.
The market share for 2019 was 61.7% for pharmaceutical and biotechnology firms and is projected to demonstrate positive growth in the future. The segment rise is attributed to the growing use in the innovative product discovery phase of clinical testing applications for clinical trials. In 2019, USD 340.8 million was estimated for 2019 for the segment Clinical Research Organizations (CROs). The growing emphasis on clinical trials outsourcing would speed up growth of this segment in pharmaceutical companies. Clinical research spending in R&D will continue to drive segment production.
Growing innovation in testing and CTMS production by leading businesses and policy agencies, North America dominated the global demand for a Clinical Trial Management System. In 2019, a total of 322,282 researches were recorded for clinical trials, 34% from the US and 66% from other countries, according to the database of ClinicalTrials.gov. The Asia-Pacific clinical trial management system market is expected to rise fastest in the forecast period due to the growing CTMS solution client base, rising demand for CMTS in the main markets worldwide, and favorable government policies for healthcare IT development in the region. Countries in Asia-Pacific are fueling market growth in this region with increasing sedentary lifestyles. On the other hand, due to the lack of knowledge and low wages, particularly in Africa, the Middle East and Africa hold the least share in the global market for clinical trials management systems.
Key Players
Major players included in this report are Medidata Solutions Inc., Oracle Corporation, Merge Healthcare Incorporated, PAREXEL International Corporation, MedNet Solutions, Inc., Bio-Optronics, Inc., BioClinica, eClinForce, Inc., Forte Research Systems, Inc., DSG, Inc., and others.
Data errors between systems need to be eliminated so that the data reconciliation activities are reduced and accurate and up-to - date information is ensured for clinical trials. However, the management of multiple applications with incompatible data and capabilities culminated in a severe loss of consistency of clinical results through specific implementations for some implementation areas. Due to the greater use of electronic data collection (EDC) and other technologies, the number of data duplication and process redundancies has increased with the increase in the number of applications concerned. The introduction of a clinical trial management program in recent years has accelerated the development of an advanced application package to simplify workflows and enhance usability. Increasing demand for these systems to improve efficiency and decrease the need for human capital to supply knowledge would drive the development of the sector of the clinical trial programs during the forecast period.
The global clinical trial management system market is segmented as below:
Market Segmentation
Clinical Trial Management System Market By Mode of Delivery
Cloud-based
On-premise
Clinical Trial Management System Market By Offering
Software
Services
Clinical Trial Management System Market By End User
Healthcare Companies
Contract Research Organizations (CROs)
Medical Devices Companies
Others (Research Institutes, Hospitals, and Others)
Clinical Trial Management System Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Clinical Trial Management System
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Clinical Trial Management System Market By Mode of Delivery
1.2.2.1. Global Clinical Trial Management System Market Revenue and Growth Rate Comparison By Mode of Delivery(2020-2027)
1.2.2.2. Global Clinical Trial Management System Market Revenue Share By Mode of Delivery in 2019
1.2.2.3. Cloud-based
1.2.3. Clinical Trial Management System Market By Offering
1.2.3.1. Global Clinical Trial Management System Market Revenue and Growth Rate Comparison By Offering (2020-2027)
1.2.3.2. Global Clinical Trial Management System Market Revenue Share By Offering in 2019
1.2.3.2.1. Software
1.2.3.2.2. Services
1.2.4. Clinical Trial Management System Market By End User
1.2.4.1. Global Clinical Trial Management System Market Revenue and Growth Rate Comparison By End User(2020-2027)
1.2.4.2. Global Clinical Trial Management System Market Revenue Share By End User in 2019
1.2.4.2.1. Healthcare Companies
1.2.4.2.2. Contract Research Organizations (CROs)
1.2.4.2.3. Medical Devices Companies
1.2.4.2.4. Others (Research Institutes, Hospitals, and Others)
1.2.5. Clinical Trial Management System Market By Geography
1.2.5.1. Global Clinical Trial Management System Market Revenue and Growth Rate Comparison by Geography (2020-2027)
1.2.5.2. North America Clinical Trial Management System Market Revenue and Growth Rate(2020-2027)
1.2.5.3. Europe Clinical Trial Management System Market Revenue and Growth Rate(2020-2027)
1.2.5.4. Asia-Pacific Clinical Trial Management System Market Revenue and Growth Rate(2020-2027)
1.2.5.5. Latin America Clinical Trial Management System Market Revenue and Growth Rate(2020-2027)
1.2.5.6. Middle East and Africa (MEA) Clinical Trial Management System Market Revenue and Growth Rate(2020-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING Clinical Trial Management System ANALYSIS
3.1. Capacity and Commercial Production Date of Global Clinical Trial Management System Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Clinical Trial Management System Major Manufacturers in 2019
3.3. R&D Status and Manufacturing End-User of Global Clinical Trial Management System Major Manufacturers in 2019
3.4. Raw Materials End-Users Analysis of Global Clinical Trial Management System Major Manufacturers in 2019
CHAPTER 4. Clinical Trial Management System MARKET By Mode of Delivery
4.1. Global Clinical Trial Management System Revenue By Mode of Delivery
4.2. Cloud-based
4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3. On-premise
4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 5. Clinical Trial Management System MARKET By Offering
5.1. Global Clinical Trial Management System Revenue By Offering
5.2. Software
5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Services
5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 6. Clinical Trial Management System MARKET By End User
6.1. Global Clinical Trial Management System Revenue By End User
6.2. Healthcare Companies
6.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.3. Contract Research Organizations (CROs)
6.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.4. Medical Devices Companies
6.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.5. Others (Research Institutes, Hospitals, and Others)
6.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 7. NORTH AMERICA Clinical Trial Management System MARKET BY COUNTRY
7.1. North America Clinical Trial Management System Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2. North America Clinical Trial Management System Market Revenue Share Comparison, 2020 & 2027 (%)
7.3. U.S.
7.3.1. U.S. Clinical Trial Management System Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
7.3.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
7.4.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
CHAPTER 8. EUROPE SMART REFRIGERATOR MARKET BY COUNTRY
8.1. Europe Clinical Trial Management System Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. Europe Clinical Trial Management System Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
8.5.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
8.6.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
8.7.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
CHAPTER 9. ASIA-PACIFIC Clinical Trial Management System MARKET BY COUNTRY
9.1. Asia-Pacific Clinical Trial Management System Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Asia-Pacific Clinical Trial Management System Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
9.8.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
9.8.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
CHAPTER 10. LATIN AMERICA Clinical Trial Management System MARKET BY COUNTRY
10.1. Latin America Clinical Trial Management System Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Latin America Clinical Trial Management System Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA Clinical Trial Management System MARKET BY COUNTRY
11.1. Middle East & Africa Clinical Trial Management System Market Revenue and Growth Rate, 2020 - 2027 ($Million)
11.2. Middle East & Africa Clinical Trial Management System Market Revenue Share Comparison, 2020 & 2027 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Mode of Delivery, 2020 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Offering, 2020 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By End User, 2020 - 2027 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. Medidata Solutions Inc.
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Oracle Corporation
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Merge Healthcare Incorporated
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. PAREXEL International Corporation
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. MedNet Solutions, Inc
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Bio-Optronics, Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. StrategiesTorpedo Inc.
12.7. BioClinica
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. eClinForce, Inc.
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Forte Research Systems, Inc.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolioa
12.9.5. Key Developments
12.9.6. Strategies
12.10. DSG, Inc.
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Others
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
